Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer - A pilot study

Journal of Gastroenterology

Volumn 32, Issue 4, 1997, Pages 513-520

  Ikeda, Kenji ^a,b   Saitoh, Satoshi ^a,b   Suzuki, Yoshiyuki ^a,b   Tsubota, Akihito ^a,b   Koida, Isao ^a,b   Kobayashi, Masahiro ^a,b   Arase, Yasuji ^a,b   Chayama, Kazuaki ^a,b   Murashima, Naoya ^a,b   Kumada, Hiromitsu ^a,b  

^a TORANOMON HOSPITAL   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

Chemotherapy; Lipiodol; Multiple small hepatocellular carcinoma; SMANCS (styrene maleic acid neocarzinostatin)

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTINEOPLASTIC AGENT; IODINATED POPPYSEED OIL; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CANCER SIZE; CHOLANGITIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; EPIGASTRIC PAIN; FEMALE; FEVER; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CANCER; LIVER CELL CARCINOMA; MALE; PORTAL PHLEBOGRAPHY; PRIORITY JOURNAL; TUMOR VASCULARIZATION; VOMITING;

EID: 8544236960     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02934092     Document Type: Article

References (31)

1. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Cancer 1987;60:1400-1411.
2. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan: Clinicopathological features and results of surgical treatment. Ann Surg 1990;211:277-287.
3. Okuda K. Early detection of hepatocellular carcinoma. Hepatology 1986;6:729-738.
4. Ebara M, Ohto M, Shinagawa T, et al. Natural history of minute hepatocellular carcinoma smaller than 3 cm complicating cirrhosis. A study in 22 patients. Gastroenterology 1986;90:289-298.
5. Wheeler PG, Melia W, Dubbins P, et al. Non-operative arterial embolization in primary liver tumours. BMJ 1979;2:242-244.
6. Chuang VP, Wallace S. Hepatic arterial embolization in the treatment of hepatic neoplasms. Radiology 1981;140:51-58.
7. Okamura J, Horikawa S, Fujiyama T, et al. An appraisal of transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies. World J Surg 1982;6:352-357.
8. Yamada R, Sato M, Kawabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397-401.
9. Lin DY, Liaw YF, Lee TY, et al. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Gastroenterology 1988;94:453-456.
10. Ikeda K, Kumada H, Saitoh S, et al. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 1991;68:2150-2154.
11. Konno T, Maeda H, Iwai K, et al. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: A preliminary report. Eur J Cancer Clin Oncol 1983;19:1055-1065.
12. Maeda H, Matsumoto T, Konno T, et al. Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on Smancs. J Protein Chem 1984;3:181-193.
13. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs. Cancer Res 1986;46:6387-6392.
14. Oda T, Maeda H. Binding to and internalization by cultured cells of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrene-maleic acid copolymer. Cancer Res 1987;47:3206-3211.
15. Ohtsuka N, Konno T, Miyauchi Y, et al. Anticancer effects of arterial administration of the anticancer agent SMANCS with Lipiodol on metastatic lymph nodes. Cancer 1987;59:1560-1565.
16. Konno T. Targeting chemotherapy for hepatoma: Arterial administration of anticancer drugs dissolved in Lipiodol. Eur J Cancer 1992;28:403-409.
17. Jinno K, Moriwaki S, Tanada M, et al. Clinicopathological study on combination therapy consisting of arterial infusion of Lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 1992;31(Suppl I): S7-S12.
18. Shinagawa T, Ohto M, Kimura K, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology 1984;86:495-502.
19. Lin TY, Lee CS, Chen KM, et al. Role of surgery in the treatment of primary carcinoma of the liven a 31-year experience. Br J Surg 1987;74:839-842.
20. Yamanaka N, Okamoto E, Toyosaka A, et al. Prognostic factors after hepatectomy for hepatocellular carcinomas: a univariate and multivariate analysis. Cancer 1990;65:1104-1110.
21. Ikeda K, Saitoh S, Tsubota A, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993;71:19-25.
22. Seldinger SI. Catheter replacement of the needle in percutaneous arteriography. Acta Radiol 1952;39:368-376.
23. Maki S, Konno T, Maeda H. Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer 1985;56:751-757.
24. Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958;53:457-481.
25. SAS Institute Cary, NC, USA: SAS/STAT Usder's Guide, Release 6.03 Edition, 1988.
26. Courtice, FC. The origin of lipoprotein in lymph. In: HS Meyersen (chairman), Lymph and lymphatic system. Springfield: CC Thomas, 1963:89-126.
27. Iwai K, Maeda H, Konno T. Use of oily contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and X-ray image. Cancer Res 1984;44:2115-2121.
28. Cottone M, Virdone R, Fusco G, et al. A symptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment. Gastroenterology 1989;96:1566-1571.
29. Groupe d'Etude et de Traitment du Carcinome Hepatocellulaire. A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332:1256-1261.
30. Kan Z, Sato M, Ivancev K, et al. Distribution and effect of iodized poppyseed oil in the liver after hepatic artery embolization: Experimental study in several animal species. Radiology 1993;186:861-866.
31. Yamada R, Kishi K, Sato M, et al. Transcatheter arterial chemoembolization (TACE) in the treatment of unresectable liver cancer. World J Surg 1995;19:795-800.